Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Aims to identify and build novel early-stage collaborations
June 5, 2013
By: Tim Wright
Editor-in-Chief, Contract Pharma
Johnson & Johnson Innovation has opened its California Innovation Center, one of four regional hubs. The goal of the California Innovation Center is to advance healthcare through science and technology collaborations with regional innovators for diverse early stage innovation projects. “The California Innovation Center is part of J&J’s global innovation strategy to advance human health by collaborating with the world’s leading scientists and entrepreneurs,” said Paul Stoffels, M.D., J&J chief scientific officer and worldwide chairman, Pharmaceuticals. “We look forward to deepening connections within the west coast life science ecosystem and nurturing healthcare innovation as well as economic prosperity in the region.” Along with the opening of the CA center, J&J Innovation entered its first collaboration and new initiatives in the area. Second Genome has entered an agreement with Janssen Biotech, Inc. as part of a research collaboration with J&J Innovation and its California Innovation Center and Janssen R&D, LLC, to explore microbiome mechanisms and their potential role in ulcerative colitis. The company also launched the J&J Innovator Program, an initiative designed to foster idea generation and company formation around breakthrough innovations. The program provides funding, resources and guidance to entrepreneurs who have revolutionary science at the earliest stages of development. David H. Kirn, M.D. is the first to be funded through the program. Dr. Kirn is the founder of Jennerex, a private clinical-stage biotherapeutics company focused on the development and commercialization of targeted oncolytic immunotherapies for solid tumors. Additionally, through a collaboration between J&J Innovation and the California Institute for Quantitative Biosciences (QB3), Janssen Labs is expanding into the San Francisco Bay Area through an exclusive agreement to create a 5,000-sq.-ft. Janssen Labs @QB3 within QB3’s 24,000-sq.-ft. facility. Companies will have access to QB3’s resources, which include legal and business advisors, assistance in grant writing for federal Small Business Innovation Research funds, and access to high-end equipment and technology in University of California, San Francisco facilities.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !